BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B

e vs mg

Mechanistic comparison of e 64c and mg 132 based on molecular target overlap from BindingDB and ChEMBL binding affinity data.

2
Shared Targets
20%
Jaccard Similarity
20%
IDF-Weighted Similarity
Jaccard measures raw target overlap. IDF-weighted downweights promiscuous hub targets (e.g. CYP enzymes) that bind many compounds non-specifically.

Evidence Comparison

e 64c
Evidence Score
0
PubMed Studies
View full profile →
mg 132
Evidence Score
0
PubMed Studies
View full profile →

Target Overlap

e and mg share 2 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.200 means 20% of the combined target set is bound by both compounds. The IDF-weighted score of 0.197 accounts for non-specific binding to metabolic enzymes.

Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.

Frequently Asked Questions

What do e and mg have in common?
e and mg share 2 molecular targets with a Jaccard similarity of 20%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can e and mg be combined?
e and mg share 2 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: e or mg?
In the BiohacksAI corpus: e has 0 PubMed-indexed studies, mg has 0 studies.

Related Comparisons

Similar to e

e vs calpeptin2 targetse vs aloxistatin2 targetse vs e3 targetse vs leupeptin2 targets

Similar to mg

mg vs marizomib3 targetsmg vs ixazomib3 targetsmg vs calpeptin3 targetsmg vs e4 targetsmg vs epoxomycin3 targets
View full e profile →View full mg profile →Browse all substances →